| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |